This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


The New Cholinesterase Inhibitors for Alzheimer’s Disease, Part 2: Illustrating Their Mechanisms of Action

Stephen M. Stahl

Published: October 31, 2000

Article Abstract
In last month’s BRAINSTORMS feature, we discussed the distinctive pharmacologic mechanisms of action of 3 new acetylcholinesterase inhibitors, namely donepezil (Aricept), rivastigmine (Exelon), and galantamine (Reminyl).

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: